Successful management of life-threatening disseminated intravascular coagulopathy due to metastatic melanoma

Intern Med J. 2014 Feb;44(2):207-8. doi: 10.1111/imj.12342.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Brain Neoplasms* / diagnosis
  • Brain Neoplasms* / secondary
  • Disseminated Intravascular Coagulation* / blood
  • Disseminated Intravascular Coagulation* / drug therapy
  • Disseminated Intravascular Coagulation* / etiology
  • Disseminated Intravascular Coagulation* / physiopathology
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Indoles / administration & dosage*
  • Melanoma* / blood
  • Melanoma* / complications
  • Melanoma* / drug therapy
  • Melanoma* / pathology
  • Melanoma* / physiopathology
  • Middle Aged
  • Mutation
  • Neoplasm Staging
  • Proto-Oncogene Proteins B-raf* / antagonists & inhibitors
  • Proto-Oncogene Proteins B-raf* / genetics
  • Sulfonamides / administration & dosage*
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Vemurafenib

Substances

  • Antineoplastic Agents
  • Indoles
  • Sulfonamides
  • Vemurafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf